Atria Investments Inc Has $8.31 Million Stock Holdings in CME Group Inc. $CME

Atria Investments Inc raised its holdings in CME Group Inc. (NASDAQ:CME) by 10.2% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 30,768 shares of the financial services provider’s stock after acquiring an additional 2,845 shares during the quarter. Atria Investments Inc’s holdings in CME Group were worth $8,313,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Empowered Funds LLC grew its position in shares of CME Group by 11.5% during the 1st quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider’s stock worth $2,660,000 after buying an additional 1,037 shares during the period. RFG Advisory LLC bought a new position in CME Group during the 2nd quarter worth approximately $716,000. Bayforest Capital Ltd acquired a new position in CME Group during the second quarter valued at approximately $114,000. Ritholtz Wealth Management grew its holdings in CME Group by 22.6% during the second quarter. Ritholtz Wealth Management now owns 5,455 shares of the financial services provider’s stock valued at $1,503,000 after purchasing an additional 1,004 shares during the period. Finally, Generali Asset Management SPA SGR increased its stake in CME Group by 91.7% in the second quarter. Generali Asset Management SPA SGR now owns 7,550 shares of the financial services provider’s stock valued at $2,081,000 after purchasing an additional 3,612 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

Key CME Group News

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME raised shareholder payouts — the board declared a Q1 quarterly dividend of $1.30 (up from $1.25) and an annual variable dividend of $6.15 based on 2025 results (total ≈ $2.2B), both payable March 26; that boosts cash return to investors. CME Group Declares Annual Variable Dividend and Q1 2026 Quarterly Dividend
• Positive Sentiment: Analyst price-target lift — Rothschild & Co Redburn raised its CME price target to $333 from $300 (still a “neutral” rating), implying roughly 9.7% upside versus recent levels, which can support buying interest. Rothschild & Co Redburn Adjusts Price Target on CME Group to $333 From $300, Maintains Neutral Rating
• Positive Sentiment: New product rollout and execution — CME reported first trades in new Cardano, Chainlink and Stellar crypto futures and is actively exploring a rare-earths futures contract; these product additions expand fee pools and diversify revenue. CME Group Announces First Trades for New Cardano, Chainlink and Stellar Cryptocurrency Futures CME Weighs Launching First-Ever Rare Earth Futures Contract / Reuters
• Positive Sentiment: Asia expansion — reports say CME plans to list Taiwan and Hong Kong warehouses for aluminium futures in Asia, a move that could deepen regional market presence and increase volumes. Exclusive: CME to list Taiwan, Hong Kong warehouses in Asia aluminium push, sources say
• Neutral Sentiment: CFTC advisory involvement — the CFTC formed an Innovation Advisory Committee that includes a CME executive; this provides regulatory engagement but unclear near-term financial impact. CFTC Forms Innovation Advisory Committee With 35 Crypto and Finance Industry Leaders
• Neutral Sentiment: Board slate announced — CME named director nominees for the annual meeting; routine governance news that is unlikely to move the stock materially. CME Group Inc. Names Slate of Director Nominees
• Neutral Sentiment: Analyst/earnings commentary — recent analyst-question coverage from the Q4 call provides context for growth drivers but contains no new guidance. 5 Must-Read Analyst Questions From CME Group’s Q4 Earnings Call
• Negative Sentiment: Short-interest reporting is inconsistent — filings flagged a “significant increase” in February short interest but published data show zeros/NaN, creating ambiguity; if short interest is actually rising, that could add downward pressure.

CME Group Trading Up 0.5%

Shares of CME stock opened at $303.07 on Friday. The stock’s fifty day simple moving average is $279.82 and its 200 day simple moving average is $274.00. The company has a quick ratio of 1.02, a current ratio of 1.03 and a debt-to-equity ratio of 0.12. CME Group Inc. has a twelve month low of $244.43 and a twelve month high of $309.35. The firm has a market capitalization of $109.29 billion, a P/E ratio of 27.16, a P/E/G ratio of 3.28 and a beta of 0.27.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share for the quarter, beating analysts’ consensus estimates of $2.75 by $0.02. CME Group had a net margin of 62.45% and a return on equity of 14.65%. The business had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the prior year, the firm posted $2.52 EPS. The company’s revenue for the quarter was up 8.1% compared to the same quarter last year. As a group, sell-side analysts predict that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, March 26th. Stockholders of record on Tuesday, March 10th will be paid a $1.30 dividend. This represents a $5.20 annualized dividend and a dividend yield of 1.7%. This is a boost from CME Group’s previous quarterly dividend of $1.25. The ex-dividend date of this dividend is Tuesday, March 10th. CME Group’s dividend payout ratio (DPR) is currently 44.80%.

Insider Buying and Selling at CME Group

In related news, Director William R. Shepard acquired 251 shares of the stock in a transaction on Tuesday, December 30th. The shares were acquired at an average price of $278.37 per share, with a total value of $69,870.87. Following the completion of the transaction, the director owned 258,710 shares in the company, valued at approximately $72,017,102.70. The trade was a 0.10% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Dennis Suskind sold 748 shares of the stock in a transaction on Friday, February 6th. The shares were sold at an average price of $300.00, for a total value of $224,400.00. Following the transaction, the director directly owned 2,699 shares of the company’s stock, valued at approximately $809,700. This trade represents a 21.70% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 0.30% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on CME shares. JPMorgan Chase & Co. increased their price objective on shares of CME Group from $262.00 to $266.00 and gave the stock an “underweight” rating in a research report on Thursday, February 5th. The Goldman Sachs Group increased their price objective on CME Group from $264.00 to $266.00 and gave the company a “sell” rating in a report on Monday, February 9th. Royal Bank Of Canada lifted their price objective on shares of CME Group from $295.00 to $302.00 and gave the company a “sector perform” rating in a research report on Thursday, February 5th. Bank of America upped their target price on shares of CME Group from $201.00 to $209.00 in a report on Wednesday, December 10th. Finally, UBS Group reiterated a “neutral” rating and issued a $310.00 target price on shares of CME Group in a research note on Friday, February 6th. Nine research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $299.53.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.